Frontiers in Endocrinology, 2023 · DOI: 10.3389/fendo.2023.1270350 · Published: August 24, 2023
The editorial discusses the increasing prevalence of sarcopenia, osteosarcopenia, and sarcopenic obesity due to the aging global population and advancements in healthcare, emphasizing the need for strategies to manage these conditions. It highlights research exploring biomarkers for early sarcopenia detection, the association of sarcopenia with conditions like knee osteoarthritis and neurological disorders, and the impact of body composition on mortality. The editorial concludes by advocating for multidisciplinary approaches in managing sarcopenia-related conditions, including exercise, nutrition, and pharmacological interventions, to improve patient outcomes.
Using biomarkers like fasting insulin and AST/ALT ratio for early sarcopenia screening can enable timely interventions.
Tailoring interventions based on individual needs, including exercise, nutrition, and medication, can improve outcomes for those with osteosarcopenia and sarcopenic obesity.
Collaboration among healthcare professionals is crucial for effectively managing the complexity of sarcopenia-related conditions.